InsiderDirector
David M Mott Insider Trading Activity
Every SEC Form 4 transaction reported by David M Mott, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is David M Mott buying or selling?
David M Mott reported 47 open-market buys ($154.4M) and 4 sells ($9.1M) across 51 Form 4 filings at 15 companies — a net buying position of $145.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 24, 2026)
Total Form 4 filings
51
SEC EDGAR
Companies
15
Buys (47)
$154.4M
Sells (4)
$9.1M
Insider sentiment
Net buyingNet insider flow of $145.3M in net buying, filed between Feb 27, 2018 – Feb 24, 2026.
Companies David M Mott files for
Recent David M Mott transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | ARDX | Director | Purchase | 333.3K | $1.9M |
| Jun 19, 2025 | ARDX | Director | Purchase | 200.0K | $725.9K |
| Jun 12, 2025 | ARDX | Director | Purchase | 200.0K | $737.3K |
| May 19, 2025 | ARDX | Director | Purchase | 100.0K | $329.1K |
| May 6, 2025 | ARDX | Director | Purchase | 381.4K | $1.6M |
| Feb 27, 2025 | ARDX | Director | Purchase | 77.7K | $388.7K |
| Jan 22, 2025 | ARDX | Director | Purchase | 199.0K | $992.7K |
| Dec 23, 2024 | ARDX | Director | Purchase | 213.3K | $996.6K |
| Nov 14, 2024 | ARDX | Director | Purchase | 215.9K | $996.6K |
| Nov 17, 2022 | ARDX | Director | Purchase | 567.0K | $1.0M |
| Feb 24, 2022 | ELVN | Director | Purchase | 151.5K | $219.7K |
| Feb 18, 2022 | ELVN | Director | Purchase | 45.9K | $54.7K |
| Feb 14, 2022 | ELVN | Director | Purchase | 31.8K | $39.2K |
| Sep 24, 2021 | NVAX | Director | Sale | 25.0K | $6.3M |
| Mar 29, 2021 | EPZM | Director | Purchase | 62.7K | $500.1K |
| Dec 10, 2020 | ARDX | Director | Purchase | 170.0K | $1.0M |
| Jun 26, 2020 | EPZM | Director | Purchase | 62.0K | $994.2K |
| Jun 26, 2020 | ARDX | Director | Purchase | 141.0K | $965.9K |
| Jun 24, 2020 | ARDX | Director | Purchase | 4.7K | $31.5K |
| Apr 9, 2020 | MRSN | Director | Purchase | 538.6K | $3.0M |
| Jan 28, 2020 | ADAPY | Director, 10% Owner | Purchase | 7.5M | $5.0M |
| Jul 24, 2019 | MIRM | 10% Owner | Purchase | 450.0K | $6.8M |
| Jun 28, 2019 | EPZM | Director | Sale | 52.5K | $652.1K |
| Jun 26, 2019 | EPZM | Director | Sale | 104.9K | $1.4M |
| Jun 25, 2019 | GNCA | 10% Owner | Purchase | 2.9M | $10.0M |
Showing the 25 most recent filings of 51. Screen every filing.
David M Mott insider trading FAQ
Is David M Mott buying or selling?
Across 51 SEC Form 4 filings, David M Mott reported 47 open-market purchases totaling $154.4M and 4 sales totaling $9.1M — a net buying position of $145.3M.
Which companies does David M Mott file Form 4s for?
David M Mott has reported insider transactions at 15 companies, most often AVEO PHARMACEUTICALS INC (AVEO), ARDELYX, INC. (ARDX), Epizyme, Inc. (EPZM), Adaptimmune Therapeutics PLC (ADAPY), IMARA Inc. (ELVN).
How far back does David M Mott's filing history go?
Trabud holds David M Mott's SEC Form 4 filings from Feb 27, 2018 – Feb 24, 2026, sourced directly from SEC EDGAR.
Where does Trabud get David M Mott's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track David M Mott and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener